PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
91 hedge funds and large institutions have $169M invested in Poseida Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 25 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 14
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
91
Holding in Top 10
1
Calls
$920K
Puts
$217K
Top Buyers
| 1 | +$14.9M | |
| 2 | +$2.45M | |
| 3 | +$1.58M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.31M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.19M |
Top Sellers
| 1 | -$1.13M | |
| 2 | -$716K | |
| 3 | -$454K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$402K |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$383K |